| Literature DB >> 31159173 |
Dianzhi Hou1, Laraib Yousaf2, Yong Xue3, Jinrong Hu4, Jihong Wu5, Xiaosong Hu6, Naihong Feng7, Qun Shen8.
Abstract
Mung bean (Vigna radiata L.) is an important pulse consumed all over the world, especially in Asian countries, and has a long history of usage as traditional medicine. It has been known to be an excellent source of protein, dietary fiber, minerals, vitamins, and significant amounts of bioactive compounds, including polyphenols, polysaccharides, and peptides, therefore, becoming a popular functional food in promoting good health. The mung bean has been documented to ameliorate hyperglycemia, hyperlipemia, and hypertension, and prevent cancer and melanogenesis, as well as possess hepatoprotective and immunomodulatory activities. These health benefits derive primarily from the concentration and properties of those active compounds present in the mung bean. Vitexin and isovitexin are identified as the major polyphenols, and peptides containing hydrophobic amino acid residues with small molecular weight show higher bioactivity in the mung bean. Considering the recent surge in interest in the use of grain legumes, we hope this review will provide a blueprint to better utilize the mung bean in food products to improve human nutrition and further encourage advancement in this field.Entities:
Keywords: bioactive compounds; health benefits; mung bean; peptides; polyphenols; polysaccharides
Year: 2019 PMID: 31159173 PMCID: PMC6627095 DOI: 10.3390/nu11061238
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Chemical structures of the main polyphenol constituents in the mung bean.
Polyphenol composition and relative content in the mung bean (fresh weight).
| Class | Subclass | Compound | Content | References |
|---|---|---|---|---|
| Flavonoids | Anthocyanins | Cyanidin-3-glucoside | 256.32–476.53 μg/g | [ |
| Peonidin-3-glucoside | 5.43- 8.42 μg/g | [ | ||
| Pelargonidin-3,6-malonylglucoside | 8.53–12.49 μg/g | [ | ||
| Pelargonidin-3-glucoside | 147.62–350.71 μg/g | [ | ||
| Flavonols | Quercetin | 0.17–16.2 mg/100 g | [ | |
| Myricetin | 0.03–4.26 mg/100 g | [ | ||
| Kaempferol | 0.07–6.13 mg/100 g | [ | ||
| Flavanols | Catechin | 4.39–35.36 mg/100 g | [ | |
| Flavones | Vitexin | 17.04–62.37 mg/100 g | [ | |
| Isovitexin | 22.63–73.64 mg/100 g | [ | ||
| Isovitexin-6″-O-α-L-glucoside | 1.70 mg/g | [ | ||
| Luteolin | 0.36 mg/100 g | [ | ||
| Isoflavonoids | Dulcinoside | 0.13 mg/g | [ | |
| Phenolic acids | Hydroxycinnamic acid | p-Coumaric acid | 8.17–38.34 mg/100 g | [ |
| Caffeic acid | 1.37–38.72 mg/100 g | [ | ||
| t-ferulic acid | 8.02–54.77 mg/100 g | [ | ||
| Chlorogenic acid | 0–26.55 mg/100 g | [ | ||
| Sinapic acid | 22.46 mg/100 g | [ | ||
| Hydroxybenzoic acid | Gallic acid | 1.32–9.47 mg/100 g | [ | |
| Syringic | 0–220.29 μg/g | [ | ||
| Gentisic | 25.39–138.45 μg/g | [ |
Polysaccharides isolated from the mung bean and their bioactivities.
| Compound Name | Molecular Weight (kDa) | Monosaccharide Composition (Molar Ratio, %) | Bioactivities | Reference |
|---|---|---|---|---|
| MP1 | 83 | Fuc:Ara:Xyl:Man:Gal:Glu = 8.3:2.2:67.2:20.1:2.3 | Antioxidant activities | [ |
| MP2 | 45 | Rha:Fuc:fucose:Ara:Xyl:Man:Gal:Glu = 31.8:3.5:16.7:4.6:11.7:29.1:2.5 | Antioxidant activities | [ |
| MEMP-1 | Nd 1 | Ara:Man:Gal = 0.12:1.0:0.5 | Radicals scavenging activity | [ |
| MEMP-2 | Nd | Rha:Ara:Man:Gal = 1:0.3:0.3:0.6 | Radicals scavenging activity | [ |
| MWP-1′ | 68.4 | Rha:Ara:Man:Galin = 0.4:2.6:5.3:0.7 | Immunoregulatory activities | [ |
| MWP-2′ | 52.4 | Ara:Man:Gal:Glc = 0.5:1.4:2.1:0.4 | Immunoregulatory activities | [ |
| MAP-1 | 94.2 | Rha:Ara:Glu:Gal:GalA = 1.1:0.4:0.7:0.5:0.3 | Antioxidant and immunoregulatory activity | [ |
| MAP-2 | 60.4 | Xyl:Rha:Gal:Glu:GalA = 0.4:1.4:1.6:0.5:0.2 | Antioxidant and immunoregulatory activity | [ |
| WSP | 20–300 | Ara:Man:Gal:Glu = 3.5:12:66:18.5 | Nd | [ |
| HWSP | 15–150 | Rha:Ara:Xyl:Man:Gal:Glu = 2.5:34:5:8:33.5:17 | Immunomodulatory activity | [ |
| Pectins | 40–1200 | Rha:Ara:Xyl:Gal:Glu = 2.6:46:8:26.4:17 | Immunomodulatory activity | [ |
| Hemicellulose A | 15–350 | Ara:Xyl:Man:Gal:Glu = 8.5:23:2:9:57.5 | Nd | [ |
| Hemicellulose B | 100–1800 | Rha:Ara:Xyl:Gal:Glu = 2.5:43:7:28:19.5 | Immunomodulatory activity | [ |
| Arabinogalactan | 1200 | Rha:Ara:Xyl:Gal:Glu = 5:60:2:32:1 | Macrophage activation | [ |
1 Nd: No data were found.Mung bean polysaccharide 1 (MP1); mung bean polysaccharide 2 (MP2); microwave extraction mung polysaccharide-1 (MEMP-1); microwave extraction mung bean polysaccharide-2 (MEMP-2); water-soluble mung bean polysaccharide-1′ (MWP-1′); water-soluble mung bean polysaccharide-2′ (MWP-2′); alkali-extractable mung bean polysaccharide-1 (MAP-1); alkali-extractable mung bean polysaccharide-2 (MAP-2,); water-soluble polysaccharide (WSP); hot water soluble polysaccharide (HWSP); rhamnose (Rha); fucose (Fuc); arabinose (Ara); xylose (Xyl); mannose (Man); galactose (Gal); glucose (Glu).
In vitro studies of the mung bean and its active compounds in health benefits.
| Health Benefits | Model | Type of Extract/Constituents | Dose/Reaction System | Experimental Outcome | Reference |
|---|---|---|---|---|---|
| Hypoglycemic properties | Biochemical tests | Lignans and flavonoids | 20 μL/1650 μL | Inhibited the activity of α-glucosidase | [ |
| Biochemical tests | Vitexin and isovitexin | 500 ppm, 100 μm | Inhibited the formation of advanced glycation end products | [ | |
| Biochemical tests | Phenolic compounds | 50 μL/200 μL, 1 mL/3 mL | Inhibited the activity of α-glucosidase and the formation of advanced glycation end products | [ | |
| Biochemical tests | Aqueous extracts of raw, boiled, and sprouted mung bean | 20 μL/220 μL, 40 μL/260 μL | Inhibited the activity of α-glucosidase and α-amylase | [ | |
| Biochemical tests | Aqueous extract of bioprocessed mung bean | 800 μL/6 mL | Inhibited the activity of α-Amylase | [ | |
| Biochemical tests | Ethanolic extracts of whole mung bean, cotyledon, and hull | 0.1 mL/1 mL | Inhibited the activity of aldose reductase | [ | |
| Biochemical tests | Ethanolic extract of mung bean seed coat | 5 mg/mL | Inhibited the activity of α-glucosidase | [ | |
| Hypolipidemic properties | 3T3-L1 preadipocytes | Vitexin and isovitexin | 25, 50 and 100 μM | Decreased fat accumulation | [ |
| Antihypertensive properties | Biochemical tests | Mung bean protein hydrolysates | 5, 7.5, 10, 12.5, 15, 20 and 25 μg/mL | Exhibited ACE-I inhibitory activity | [ |
| Biochemical tests | Vicilin protein (storage protein of mung bean) hydrolysate | 0.2–1.0 mg/mL | Exhibited ACE-I inhibitory activity | [ | |
| Biochemical tests | Mung bean protein hydrolysate | 100 μg/mL | Exhibited ACE-I inhibitory activity | [ | |
| Biochemical tests | Mung bean protein hydrolysate | 10 mg protein/mL | Exhibited ACE-I inhibitory activity | [ | |
| Anticancer properties | Human breast adenocarcinoma cells (MCF-7), human cervical cancer cells (Hela) | Proteins isolated from mung bean aqueous extract | 62.5, 125, 250, 500 and 1000 μg/mL | Exhibited the anti-proliferation activities | [ |
| Human breast adenocarcinoma cells (MCF-7 and MDA-MB-231) | vicilin protein (storage protein of mung bean) hydrolysate | 10, 25, 50, 75 and 100 mg/mL | Exhibited the anti-proliferation activities | [ | |
| Human hepatoma cells (Bel-7402) | Mungoin- a novel mung bean protease inhibitor | 10, 50, 100 and 200 μM | Exhibited the anti-proliferation activities | [ | |
| Digestive system cancer cells (CAL27, AGS, HepG2, SW480 and Caco-2), prostate cancer cells (DU145), ovary cancer cells (SK-OV-3), breast cancer cells (MCF-7), and leukemia cells (HL-60) | Phenolics | 0.125, 0.25, 0.5, 1, 2 and 5 mg/mL | Exhibited the anti-proliferation activities | [ | |
| Human pulmonary carcinoma cell, human gastric carcinoma cells (SNU-601) | Aqueous, ethyl acetate, methanol, n-hexane, n-butanol extracts of mung bean seeds and sprouts | Nd 1 | Exhibited the anti-proliferation activities | [ | |
| Cervix adenocarcinoma cells (HeLa; ATCC CCL-2), hepatocellular carcinoma (HepG2; ATCC HB-8065) | Methanol Extracts of mung bean sprouts | 9.37 to 300 mg/mL, 10.25 to 164 mg/mL, 3.12 to 100 mg/mL, 0.31 to 10 mg/mL | Increased levels of anticancer cytokine (TNF-α and IFN-β) | [ | |
| Immunomodulatory activity | Murine macrophage RAW264.7 cells | Verbascose | 25, 50, 100, 200, and 400 μg/mL | Enhanced the ability of devouring neutral red of peritoneal macrophages | [ |
| Murine macrophage RAW264.7 cells | Arabinogalactan | 10, 50, 100, and 200 μg/mL | Induced the release of NO, TNF-α, IL-6, and IL-1β | [ | |
| Male Balb/c mice splenocyte (8–10 week-old) | Aqueous extract of fermented mung bean | 2.3 mg/mL | Enhanced splenocyte proliferation | [ | |
| Murine macrophage RAW264.7 cells | Water-extractable polysaccharides from mung beans | 50, 100 and 200 μg/mL | Stimulate the production of NO, TNF-α and IL-6 | [ | |
| Murine macrophage RAW264.7 cells | Alkali-extractable polysaccharides from mung beans | 50, 100 and 200 μg/mL | Stimulated the production of NO, TNF-α and IL-6 | [ | |
| Male Wistar splenocytes (8 week-old), murine macrophage RAW264.7 cells | Water soluble (cold and hot water, 55 °C), EDTA soluble (0.5%, Pectins), alkali-soluble (10%, Hemicellulose A and B) polysaccharides isolated from mung beans | 0.1–100 μg/mL, 50–1000 μg/mL | Enhanced splenocyte proliferation | [ | |
| T helper cells (transgenic OT-II mice) | Saponins | 50 and 100 μg/mL | Inhibited Th cell proliferation | [ | |
| Murine macrophage RAW264.7 cells | Vitexin and isovitexin | 100 μg/mL | Inhibited the expression of IL-1β, IL-6, and COX-2 mRNA | [ | |
| Murine macrophage RAW264.7 cells | Aqueous extracts of untreated, germinated, and fermented mung beans | 2.5 and 5 mg/mL | Decreased level of NO | [ | |
| Murine macrophage RAW264.7 cells and human monocyte U-937 cells | Aqueous extract of mung bean seed coat | 0.1, 0.2, 0.8, 4, 8, and 15 mg/L | Reduced both intra- and extracellular HMGB1 levels in endotoxin-stimulated macrophages | [ | |
| Biochemical tests | Ethanolic extracts of whole mung bean, cotyledon, and hull | 1 mL/5 mL | Inhibited the activity of protease | [ | |
| Macrophages cells (J774) | Ethanolic extract of mung bean | 3.7 mg/mL | Decreased the mRNA expression of IL-1β, IL-6, IL-12β, TNF-α, and iNOS | [ | |
| Anti-melanogenesis properties | Biochemical tests | Vitexin and isovitexin | 10 and 15 μM | Inhibited tyrosinase activity | [ |
| Mouse melanoma cells (B16F1) | Vitexin and isovitexin | 10–250 μg/mL | Inhibited melanogenesis | [ | |
| Mouse melanoma cells (B16) | Tannins | 50, 100, 200, and 400 μg/mL | Inhibited cell proliferation, cellular tyrosinase activity, and melanogenesis | [ | |
| Biochemical tests | Antityrosinase | 20, 40, 60, 80, 120, 160, and 200 μg/mL | Inhibited the monophenolase and diphenolase activities | [ | |
| Biochemical tests | Ethanolic extract of mung beans | 15 mg/mL | Inhibited tyrosinase activity | [ | |
| Biochemical tests | Aqueous, ethyl acetate, methanol, n-hexane, n-butanol extracts of mung bean seeds and sprouts | Nd | Inhibited tyrosinase activity | [ |
1 Nd: No data were found. Interleukin-6 (IL-6); monocyte chemoattractant protein-1 (MCP-1); interleukin 1 beta (IL-1β); cyclooxygenase-2 (COX-2); nitric oxide (NO); high mobility group box-1 (HMGB1); interleukin 12β (IL-12β), tumor necrosis factor alpha (TNF-α); inducible nitric oxide synthase (iNOS); interferon-α (IFN-α); interferon-γ (IFN-γ); interleukin-4 (IL-4); interferon-β (IFN-β); interleukin-2 (IL-2); angiotensin-converting enzyme (ACE); ethylenediaminetetraacetic acid (EDTA).
Animal studies on the mung bean and its active compounds in health benefits.
| Health Benefits | Model | Dose and Duration | Experimental Outcome | Reference |
|---|---|---|---|---|
| Hypoglycemic properties | Wistar rats in a cholesterol-enriched diet | Raw, boiled, and sprouted mung beans (30%) in diet supplementation for 5 weeks | ↓ Blood glucose, insulin, TG, non-HDL-C, HDL-C | [ |
| STZ-induced diabetes rats | Fermented mung bean seed coat (100 and 200 g/kg) in diet supplementation for 21 days | ↓ Feed intake, body weight, | [ | |
| Alloxan-induced diabetes mice | Aqueous extracts of fermented and nonfermented mung bean (200 and 1000 mg/kg) for 10 days | ↓ Blood glucose, TG, LDL, NO level | [ | |
| Diabetic db/db mice | Ethanolic extract of mung bean seed coat (1%) in diet supplementation for 7 weeks | ↓ Fasting serum glucose, blood glycated hemoglobin, HOMA-IR | [ | |
| Diabetic KK-Ay mice | Ethanolic extracts of mung bean sprout and mung bean seed coat (2 and 3 g/kg) for 5 weeks | ↓ Body weight, blood glucose level, C-peptide level, glucagon level, TC | [ | |
| Hypolipidemic properties | Fructose-loaded spontaneously hypertensive rats | Mung bean sprouts (30%) in diet supplementation for 46 days | ↓ TG, TC | [ |
| Hamsters in a cholesterol-enriched diet | Mung bean (1% and 2%) in diet supplementation for 6 weeks | ↓ Plasma TC, TG, non-HDL-C, non-HDL-C/HDL-C, and TC/HDL-C, liver cholesterol | [ | |
| High-fat-diet-induced rats | The juice of mung bean sprout (0.67 and 1.34 mg/200 g) for 28 days | ↓ TC, TG, LDL | [ | |
| Balb/c mice in a cholesterol-enriched diet | Aqueous extracts of fermented and nonfermented mung beans (200 and 1000 mg/kg) for 2 weeks | ↓TC, TG, LDL, ALT, ALP | [ | |
| High-fat diet-induced male C57BL/6 mice | Mung bean protein isolate in diet supplementation (26.35%) for 4 weeks | ↓ body weight, epididymal, perirenal, and subcutaneous adipose weights, hepatic triglyceride | [ | |
| Hamsters in a cholesterol-enriched diet | Mung bean protein isolate in diet supplementation (1% and 2%) for 6 weeks | ↓ TC, TG, non-HDL-C, non-HDL-C/HDL-C, and TC/HDL-C | [ | |
| Hepatoprotective | Hamsters in a casein hypercholesterolemic diet | Cooked and germinated mung beans (as 22.1% protein source) in diet supplementation for 28 days | ↓ Relative liver weight, non-HDL-C, AST, ALT | [ |
| Methionine and choline-deficient diet induced steatohepatitis rats | Germinated mung bean power (500 and 1000 mg/kg) for 4 weeks | ↓ Lipid deposition, inflammatory infiltrate | [ | |
| High-fat-diet-induced mice | Mung bean protein isolate (replacement of casein) in diet supplementation for 4 weeks | ↓ Hepatic TG concentration | [ | |
| Effect-ethanol induced hepatotoxicity in mice | Vitexin and isovitexin (15 and 13 mg/kg) for 14 days | ↓ Serum ALT, AST | [ | |
| Effect-ethanol induced hepatotoxicity in mice | Aqueous extracts of germinated and fermented mung beans (200 and 1000 mg/kg) for 7 and 14 days | ↓ Serum ALT, AST, TG, and cholesterol | [ | |
| Acetaminophen-induced acute hepatotoxicity model in rats | Aqueous extracts of the mung bean (100, 500, and 1000 mg/kg) for a single oral administration | ↓ Serum glutamate-oxalate-transaminase, glutamate-pyruvate-transaminase | [ | |
| Antihypertensive | Spontaneously hypertensive rats | Mung bean protein isolate hydrolysates (600 mg/kg) for a single oral administration | ↓ SBP, heart rate | [ |
| Spontaneously hypertensive rats | Aqueous extracts and hydrolysates of mung bean sprouts (600 mg peptide/kg) for 8 weeks | ↓ SBD, plasma ACE activity | [ | |
| Anticancer properties | Breast cancer cells 4T1 injected mice | Aqueous extract of fermented mung bean (200 and 1000 mg/kg) for 30 days | ↓ Tumor formation | [ |
| Immunomodulatory activity | Cyclophosphamide induced-immunosuppressed model | Verbascose from mung bean (30, 90 and 270 mg/kg) for 8 days | ↑ Spleen and thymus indices | [ |
| Arachidonic acid-induced ear edema in mice | Aqueous extract of untreated, germinated, and fermented mung bean (200 and 1000 mg/kg) for single oral administration | Exhibited the edema inhibition effect | [ | |
| An animal model of sepsis induced by cecal ligation and puncture | Aqueous extract of mung bean seed coat (0.2 mL/mouse, containing 1.0 mg lyophilized extract) for 2 weeks | ↑ Survival rates | [ | |
| Complete Freund’s adjuvant-induced arthritis in rats | Ethanolic extract of mung bean (250 and 500 μg/mL) for 21 days | ↑ Body weight, percentage inhibition of paw edema, pain threshold | [ | |
| Diabetic KK-Ay mice | Ethanolic extract of mung bean (1 g/kg) for 4 weeks | ↓ Epididymal and perirenal fat weights | [ |
Note: ↑ and ↓ signs represent increase and decrease, respectively, after supplementation of the mung bean or its active compounds. Triglyceride (TG); total cholesterol (TC); non-high-density lipoprotein cholesterol (non-HDL-C); high-density lipoprotein cholesterol (HDL-C); low-density lipoprotein (LDL); free fatty acids (FFA); homeostasis model assessment of insulin resistance (HOMA-IR); superoxide dismutase (SOD); catalase (CAT); glutathione peroxidase (GSH-Px); cholesterol-7α-hydroxylase (CYP7A1); alanine aminotransferase (ALT); alkaline phosphatase (ALP); malondialdehyde (MDA); ferric ion reducing antioxidant power (FRAP); interleukin-10 (IL-10); (lipolysis marker) phosphorylated 5’ adenosine monophosphate-activated protein kinase (p-AMPK); acetyl-CoA carboxylase (ACC); proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α); phosphorylated extracellular signal-regulated protein kinases ½ (p-ERK1/2); peroxisome proliferator-activated receptor (PPARγ); phosphorylated p38 mitogen-activated protein kinase (p-p38); thiobarbituric acid reactive substances (TBARS); glutathione reductase (GR); glucose-6 phosphate dehydrogenase (G6PDH); reactive oxygen species (ROS). Systolic blood pressure (SBP); diastolic blood pressure (DBP).
Figure 2(A) Modulation of hypertension, hyperglycemia, and hyperlipidemia and inflammation by the mung bean (including seeds, sprouts, and seed coats) or its active components. (B) Schematic diagram depicting the beneficial effects of the mung bean (including seeds, sprouts, and seed coats) or its active components on metabolic responses. The mung bean or its active compounds prevented an increase in serum glucose and lipid concentrations by inhibiting the activities of the related enzymes in a carbohydrate and lipid metabolism, increasing lipolysis in the liver and adipose tissue and decreasing oxidative stress in white adipose tissue, also increasing capacity of energy metabolism in the gastrocnemius muscle. In addition, the expression levels of inflammation-related genes in the liver, muscle, and adipose tissue were inhibited. The mung bean protein was hydrolyzed into peptides with small molecular weight to reduce the blood pressure. ↑ and ↓ sign, after the mung bean or the supplementation of its active compounds, represented an increase and decrease, respectively. (Original).
Figure 3Liver histopathological changes in different experimental animals. (a) Normal group, (b) rats supplemented with a methionine-choline deficient diet, (c) rats receiving the germinated mung bean (1000 mg/kg body weight, for 4 weeks) and supplemented with a methionine-choline deficient diet. Scale bar, 200 μm; White arrow: Fibrosis. Central vein (CV); portal vein (PV) [90].